🇺🇸 FDA
Patent

US 12005081

Chimeric receptors and methods of use thereof

granted A61KA61K2239/17A61K2239/28

Quick answer

US patent 12005081 (Chimeric receptors and methods of use thereof) held by Senti Biosciences, Inc. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Senti Biosciences, Inc.
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2239/17, A61K2239/28, A61K2239/29, A61K2239/31